SPRINT.ST
Price:
$0.528
Market Cap:
$51.98M
Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism in Sweden, Europe, the United States, and Asia. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism and type 2 diabetes. Sprint Bioscience AB (publ) was founded in 2009 and is based in Huddinge, Sweden.
Industry
Biotechnology
IPO Date
2014-11-07
Stock Exchange
STO
Ticker
SPRINT.ST
According to Sprint Bioscience AB (publ)’s latest financial reports and current stock price. The company's current ROE is -184.99%. This represents a change of 173.65% compared to the average of -67.60% of the last 4 quarters.
The mean historical ROE of Sprint Bioscience AB (publ) over the last ten years is -156.34%. The current -184.99% ROE has changed 18.32% with respect to the historical average. Over the past ten years (40 quarters), SPRINT.ST's ROE was at its highest in in the March 2021 quarter at 322.31%. The ROE was at its lowest in in the March 2020 quarter at -775.62%.
Average
-156.34%
Median
-128.39%
Minimum
-505.61%
Maximum
15.94%
Discovering the peaks and valleys of Sprint Bioscience AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 12.40%
Maximum Annual ROE = 15.94%
Minimum Annual Increase = -338.22%
Minimum Annual ROE = -505.61%
Year | ROE | Change |
---|---|---|
2024 | -197.12% | 12.40% |
2023 | -1.58% | -99.26% |
2022 | -213.46% | 493.21% |
2021 | -35.98% | -92.88% |
2020 | -505.61% | 144.91% |
2019 | -206.44% | 246.08% |
2018 | -59.65% | 57.14% |
2017 | -37.96% | -338.22% |
2016 | 15.94% | -104.96% |
2015 | -321.56% | 470.00% |
The current ROE of Sprint Bioscience AB (publ) (SPRINT.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-137.39%
5-year avg
-190.75%
10-year avg
-156.34%
Sprint Bioscience AB (publ)’s ROE is greater than Cantargia AB (publ) (-166.31%), less than Saniona AB (publ) (188.36%), greater than Acarix AB (publ) (-97.75%), less than Gabather AB (publ) (233.47%), greater than LIDDS AB (publ) (-55.58%),
Company | ROE | Market cap |
---|---|---|
-166.31% | $308.78M | |
188.36% | $1.35B | |
-97.75% | $393.59M | |
233.47% | $11.40M | |
-55.58% | $12.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sprint Bioscience AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sprint Bioscience AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Sprint Bioscience AB (publ)'s ROE?
How is the ROE calculated for Sprint Bioscience AB (publ) (SPRINT.ST)?
What is the highest ROE for Sprint Bioscience AB (publ) (SPRINT.ST)?
What is the 3-year average ROE for Sprint Bioscience AB (publ) (SPRINT.ST)?
What is the 5-year average ROE for Sprint Bioscience AB (publ) (SPRINT.ST)?
How does the current ROE for Sprint Bioscience AB (publ) (SPRINT.ST) compare to its historical average?